Lampire Biological Laboratories was listed on 05 January 2026 by the sinobi ransomware group (the group's claim; Ransomware Tracker by ExposureDrift has not confirmed a breach). sinobi listed 56 organizations that month and 274 in total.
- Listed 318 days ago.
- 695 organizations were listed by all groups in January 2026, see the month.
- 49 in Healthcare that month.
- 318 in US that month.
Updated 2026-11-19 05:54 UTC. Data: public leak-site listings. How we work.
Lampire Biological Laboratories
Threat Group Post & Evidence
- Listed by
- Sinobi 274 listings in total
The listing states no data size and no ransom demand.
No capture of the original post
We only show a screenshot when we captured the group's own page ourselves. For this listing we have not, so none is shown.
The group's leak-site address is on paid plans
Free accounts see who listed this organization, when, and what the post claims. The address of the group's own page is shown to license-key holders. If you have a key, see what a license key adds.
What the group says it holds
Taken from the group's own post. Ransomware Tracker by ExposureDrift has not seen the data and cannot confirm any of this.
LAMPIRE Biological Laboratories, a pioneering biotech life science firm specializing in the creation and supply of vital biological reagents for the diagnostic and pharmaceutical industries. Our extensive offerings encompass tailor-made polyclonal and monoclonal antibody development, secondary antibodies, IgGs, BSA, animal blood, tissues, and organs. We also provide both normal and disease-state human serums and plasmas, along with cutting-edge cell media, OMNI C3 cell culture bags, contract manufacturing solutions, and an array of technical support services.
Plain-English summary AI-written
The group says it has information about LAMPIRE Biological Laboratories’ biological reagents, antibodies, blood products, tissues, organs, cell media, manufacturing services, and technical support.
Written by an AI model (openai/gpt-6-luna) from the post above. It can contain mistakes: rely on the quote, not the summary.
What to do about this listing
Choose who you are. Each step shows why it appears and, where we have one, its source. General guidance, not legal or incident-response advice.
If you work with Lampire Biological Laboratories (customer, supplier or partner)
Within 3 days
- Do not open the group's page or download the data Do not visit the leak site or download files from a listing. Holding stolen data can be unlawful, and the files can carry malware. Wait for the company's own notice. Why: A safety rule for any leak listing.
- Ask Lampire Biological Laboratories directly Write to your contact and ask whether your data, or your access to their systems, is in scope, and ask for a written statement. Your contract or data-protection law may oblige them to tell you if your data is affected: check the notification clause. Why: A listing is only the group's claim; the company is the one who can confirm what was taken.
- Review what Lampire Biological Laboratories can reach of yours List the accounts, API keys, VPN or SSO connections and shared mailboxes this company has with you. Rotate the keys you gave them and remove access they do not need. Why: Access a supplier holds is how a listing about them can become a problem for you.
Within 30 days
- Keep watching Lampire Biological Laboratories A supplier's listing can change after the first sighting: the group can add data, change the status or publish. Add the company to your supplier list to be told, and check your own domain too. Why: A listing is a moving claim, not a single event. Add to your supplier list Check your own domain
If you are Lampire Biological Laboratories
Within 3 days
- Find out what was actually taken The post names no specific kind of data, so no data-specific steps are shown. Check the group's own post and your logs to learn what is claimed and what is real. Why: The listing text names no data types.
- Retire staging and dev exposure Take non-production hosts off the internet or behind authentication, and rotate any secrets they held. Why: A passive scan found 1 non-production host(s) that are public.
- Check regulatory and stakeholder notification duties United States: state breach-notification laws apply; listed companies may also have SEC Form 8-K Item 1.05 duties for material incidents, and HIPAA applies to health data. Health data adds sector rules. This is general guidance, not legal advice: confirm current rules with counsel. Why: Listing country: United States.
General readiness for any ransomware claim (not about this listing)
- Offline, immutable backups and a restore drill Keep backups outside domain-admin reach and practise a restore; a leak does not remove the risk of re-encryption. Why: General practice for any ransomware claim; not specific to this listing.
- Look for mass file access and unusual outbound transfers Review EDR, proxy and identity logs for bulk reads, archive creation and large uploads to file-sharing services. Why: General practice for any ransomware claim; not specific to this listing.
- Phishing-resistant MFA on remote access Enforce MFA on VPN, SSO and admin panels, and retire password-only or SMS-based remote access. Why: General practice for any ransomware claim; not specific to this listing.
Listing details
Listing severity score (heuristic)
72/100 • ELEVATEDA heuristic built from sector, group, data volume and claim details. It is not evidence that a breach occurred or a measure of harm.
External Attack Surface Profile
ASM IntelligenceRun a free passive scan on your own domain to see what an attacker can see from the outside.